Due to the lack of efficiency to control malaria elicited by sub-unit vaccine preparations,
vaccination with live-attenuated Plasmodium parasite as reported 70 years ago with …

Challenges and recent progress in tropical disease drug discovery - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

The infectious agents have been known to cause disease and later it was established that
human can be protected from pathogens after the discovery of the first vaccine. Vaccines are …

Iron deficiency and malaria are two major public health problems with largely overlapping
epidemiology, and there is a complex relationship between iron and malaria. Iron deficiency …

After many years of silence, eradication of malaria is, once again, one of the top priorities on
the agenda of many international health and development agencies. To meet this idealistic …

Malaria remains a leading cause of childhood mortality, thereby highlighting the need for an
effective vaccine. R21 is a virus-like particle-based (VLP-based) vaccine displaying the …

Controlled human malaria infection (CHMI) provides a highly informative means to
investigate host-pathogen interactions and enable in vivo proof-of-concept efficacy testing of …

The use of medicinal plants in combating many tropical diseases including malaria is
gaining wide acceptance owing to their many bioactive compounds. Malaria, which is …

The malaria burden in The Gambia has decreased substantially over the last two decades.
However, despite the high coverage of standard control interventions, malaria transmission …

Among people naturally exposed to Plasmodium falciparum (Pf) in endemic areas some
naturally develop antibodies that are capable of inhibiting the development of the parasites …